East Walpole, MA, United States of America

Jon Jacobs


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jon Jacobs in Neurological Treatments

Introduction

Jon Jacobs is an accomplished inventor based in East Walpole, MA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target neurological and psychiatric disorders. With a total of two patents to his name, Jacobs is recognized for his innovative approaches to treating conditions associated with glutamate dysfunction.

Latest Patents

Jacobs' latest patents include "Naphthyridinone analogs as mGluR5 positive allosteric modulators." This invention relates to naphthyridinone analogs, derivatives, and related compounds that serve as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). The patent outlines synthetic methods for creating these compounds, pharmaceutical compositions that include them, and methods for treating neurological and psychiatric disorders linked to glutamate dysfunction. Another notable patent is "Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators." Similar to the first, this invention focuses on dihydronaphthyridinyl(organo)methanone analogs and their derivatives, emphasizing their utility in treating disorders associated with glutamate dysfunction.

Career Highlights

Jon Jacobs is affiliated with Vanderbilt University, where he continues to advance research in pharmacology and neuroscience. His work has garnered attention for its potential impact on therapeutic strategies for various neurological conditions.

Collaborations

Jacobs collaborates with esteemed colleagues, including P Jeffrey Conn and Craig William Lindsley. Their combined expertise enhances the research efforts at Vanderbilt University and contributes to the development of innovative treatments.

Conclusion

Jon Jacobs is a notable inventor whose work in developing positive allosteric modulators has the potential to transform the treatment landscape for neurological and psychiatric disorders. His contributions to pharmacology are significant and continue to influence the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…